CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Agios Pharmaceuticals Inc  (AGIO)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

AGIO's Revenue Year on Year Growth by Quarter and Year

Agios Pharmaceuticals Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
AGIO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 22.65 6.22 14.64
III Quarter September - 8.99 5.48 33.90
II Quarter June 11.35 6.98 13.22 8.41
I Quarter March 10.51 31.28 34.20 8.41
FY   21.86 69.90 59.12 65.36

Financial Statements
Agios Pharmaceuticals Inc's second quarter 2017 Revenue $ 11.35 millions AGIO's Income Statement
Agios Pharmaceuticals Inc's second quarter 2016 Revenue $ 6.98 millions Quarterly AGIO's Income Statement
AGIO's Growth by Division See AGIO's Growth by Segment

AGIO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 264.15 % -57.51 % -
III Quarter September - 64.05 % -83.83 % 440.67 %
II Quarter June 62.55 % -47.2 % 57.19 % 34.13 %
I Quarter March -66.4 % -8.54 % 306.66 % -
FY   - 18.23 % -9.55 % -



AGIO Revenue Growth Comment
Agios Pharmaceuticals Inc reported Revenue rise of 62.55% year on year in the second quarter, to $ 11.35 millions, this is lower than Agios Pharmaceuticals Inc's recent average Revenue rise of 80.51%.

Looking into second quarter results within Major Pharmaceutical Preparations industry 28 other companies have achieved higher Revenue growth. While Agios Pharmaceuticals Inc' s Revenue jump of 62.55% ranks overall at the positon no. 293 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #69
Overall #293
Revenue Y/Y Growth Statistics
High Average Low
440.84 % 80.51 % -83.83 %
(Sep 30 2014)   (Sep 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AGIO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AGIO's Competitors
Revenue Growth for Agios Pharmaceuticals Inc's Suppliers
Revenue Growth for AGIO's Customers

You may also want to know
AGIO's Annual Growth Rates AGIO's Profitability Ratios AGIO's Asset Turnover Ratio AGIO's Dividend Growth
AGIO's Roe AGIO's Valuation Ratios AGIO's Financial Strength Ratios AGIO's Dividend Payout Ratio
AGIO's Roa AGIO's Inventory Turnover Ratio AGIO's Growth Rates AGIO's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
U.s. Stem Cell, Inc.  104.34 %$ 104.345 millions
Innovus Pharmaceuticals, Inc.  99.96 %$ 99.962 millions
Adamis Pharmaceuticals Corp  97.36 %$ 97.363 millions
Biocept Inc  92.95 %$ 92.946 millions
Dimension Therapeutics, Inc.  84.27 %$ 84.268 millions
Egalet Corp  81.30 %$ 81.304 millions
Dariohealth Corp.  80.87 %$ 80.867 millions
Innoviva, Inc.  80.35 %$ 80.346 millions
Corcept Therapeutics Inc  80.28 %$ 80.283 millions
Mri Interventions, Inc.  79.01 %$ 79.005 millions
Anavex Life Sciences Corp.  77.18 %$ 77.175 millions
China Yct International Group, Inc.  76.42 %$ 76.421 millions
Pieris Pharmaceuticals, Inc.  72.70 %$ 72.702 millions
Omeros Corp  71.44 %$ 71.441 millions
Nephros Inc  68.76 %$ 68.762 millions
Teladoc, Inc.  68.34 %$ 68.344 millions
Intelgenx Technologies Corp.  67.56 %$ 67.560 millions
Keryx Biopharmaceuticals Inc  63.05 %$ 63.049 millions
Neurometrix, Inc.  62.80 %$ 62.802 millions
Agios Pharmaceuticals Inc  62.60 %$ 62.597 millions
Myokardia Inc  58.50 %$ 58.495 millions
Semler Scientific, Inc.  57.58 %$ 57.579 millions
Novabay Pharmaceuticals, Inc.  54.79 %$ 54.788 millions
Shire Plc  54.21 %$ 54.205 millions
Zynex Inc  53.44 %$ 53.439 millions
Flex Pharma, Inc.  52.16 %$ 52.163 millions
Adverum Biotechnologies, Inc.  50.81 %$ 50.814 millions
Adma Biologics, Inc.  49.64 %$ 49.638 millions
Diversicare Healthcare Services, Inc.  48.79 %$ 48.792 millions
Supernus Pharmaceuticals Inc  46.88 %$ 46.881 millions